High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74). (Q45032894)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74). (English)

1 reference

Europe PubMed Central

8 December 2017

Plasmodium vivax

0 references

1 reference

based on heuristic

inferred from title

4

object named as

Yagya D Sharma

1 reference

Europe PubMed Central

8 December 2017

author name string

Mohammad Tauqeer Alam

1

1 reference

Europe PubMed Central

8 December 2017

Hema Bora

2

1 reference

Europe PubMed Central

8 December 2017

Neeru Singh

3

1 reference

Europe PubMed Central

8 December 2017

language of work or name

0 references

publication date

10 June 2008

1 reference

Europe PubMed Central

8 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

8 December 2017

26

1 reference

Europe PubMed Central

8 December 2017

31

1 reference

Europe PubMed Central

8 December 2017

3787-3794

1 reference

Europe PubMed Central

8 December 2017

Expression and purification of a Plasmodium vivax antigen - PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

An unusual tryptophan-rich domain characterizes two secreted antigens of Plasmodium yoelii-infected erythrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Genes coding for tryptophan-rich proteins are transcribed throughout the asexual cycle of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Improved prediction of signal peptides: SignalP 3.0

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Tandem repeats finder: a program to analyze DNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Thioredoxin system in obligate anaerobe Desulfovibrio desulfuricans: Identification and characterization of a novel thioredoxin 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Extensive heterozygosity at four microsatellite loci flanking Plasmodium vivax dihydrofolate reductase gene.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Molecular insights into receptors used by malaria parasites for erythrocyte invasion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Invasion of host cells by malaria parasites: a tale of two protein families

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

A reticulocyte-binding protein complex of plasmodium vivax merozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Immunoregulation of malarial infection: balancing the vices and virtues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Prolonged expression of IFNgamma induced by protective blood-stage immunization against Plasmodium yoelii malaria.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

A challenge for the development of malaria vaccines: polymorphic target antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

The genetic diversity of Plasmodium vivax populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

Merozoite surface protein-3alpha is a reliable marker for population genetic analysis of Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

The genetic diversity of Plasmodium vivax--a review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

The neglected burden of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.05.059

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.05.059

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45032894&oldid=2067534865"